Education
Academic Background-
Ph.D. University of Glasgow, UK Clinical Pharmacology | Completed: 2011
Publications (28)
Selected Scholarly Contributions
Neuroprotective effect of different doses of vitamine D3 in diabetic-induced Alzheimer rat model.
Sameer E. Al-Harthi
2019
Neuroprotective role of vitamin D3 against insulin resistance and diabetic induced memory dysfunction in rats.
Sameer E. Al-Harthi
2019
Cardioprotective effect of marine astaxanthin on doxorubicin-induced cardiotoxicity in normal rats.
Sameer E. Al-Harthi
2019
Enhancement of doxorubicin cytotoxicity by verapamil in human breast cancer cells.
Sameer E. Al-Harthi
2019
Dimethyl sulfoxide potentiates the anticancer activity of cisplatin against the growth of lung cancer cells.
Sameer E. Al-Harthi
2019
Chemosensitizing effects of marine astaxanthin on the anti-cancer activity of doxorubicin in tumor bearing mice.
Sameer E. Al-Harthi
2019
Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity.
Sameer E. Al-Harthi
2018
Differences in the activity of endogenous bone morphogenetic protein signaling impact on the ability of induced pluripotent stem cells to differentiate to corneal epithelial-like cells.
Sameer E. Al-Harthi
2018
Concise review: Getting to the core of inherited bone marrow failures.
Sameer E. Al-Harthi
2017
An induced pluripotent stem cell patient specific model of complement factor H (Y402H) polymorphism displays characteristic features of age-related macular degeneration and indicates a beneficial role for UV light exposure.
Sameer E. Al-Harthi
2017
Enhancement of efficacy and reduced toxicity of cisplatin through Self Nanoemulsifying Drug Delivery System (SNEDDS).
Sameer E. Al-Harthi
2017
Benefits of medication antidote signals for the detection of potential adverse drug reactions over contemporary methods of pharmacovigilance in hospitalized children.
Sameer E. Al-Harthi
2017
Allelic variance among ABO blood group genotypes in a population from the Western region of Saudi Arabia.
Sameer E. Al-Harthi
2016
Dilemmas of the causality assessment tools in the diagnosis of adverse drug reactions.
Sameer E. Al-Harthi
2016
Serum interleukin-33 level in Saudi children with inflammatory bowel disease.
Sameer E. Al-Harthi
2015
Comparative study of analgesic and anti-inflammatory effects of Commiphora opobalsamum with diclofenac in rodents.
Sameer E. Al-Harthi
2015
The possible antianginal effect of allopurinol in vasopressin-induced ischemic model in rats.
Sameer E. Al-Harthi
2015
Detection of adverse drug reactions by medication antidote signals and comparison of their sensitivity with common methods of ADR detection.
Sameer E. Al-Harthi
2015
Perceptions and knowledge regarding antimicrobial stewardship among clinicians in Jeddah, Saudi Arabia.
Sameer E. Al-Harthi
2015
Modulatory role of resveratrol on cytotoxic activity of cisplatin, sensitization and modification of cisplatin resistance in colorectal cancer cells.
Sameer E. Al-Harthi
2015
Amelioration of doxorubicin-induced cardiotoxicity by resveratrol.
Sameer E. Al-Harthi
2014
Adverse drug reactions in hospitalized pediatric patients of saudi arabian university hospital and impact of pharmacovigilance in reporting ADR.
Sameer E. Al-Harthi
2013
2012
Entecavir treatment of children 2-16 years of age with chronic hepatitis B infection.
Sameer E. Al-Harthi
2012
Modulation of doxorubicin cytotoxicity by resveratrol in a human breast cancer cell line.
Sameer E. Al-Harthi
2012
Impact of pharmacovigilance on adverse drug reactions reporting in hospitalized internal medicine patients at Saudi Arabian teaching hospital.
Sameer E. Al-Harthi
2012
Deletion of the Dual Specific Phosphatase-4 (DUSP-4) gene reveals an essential non-redundant role for MAP Kinase Phosphatase-2 (MKP-2) in proliferation and cell survival.
Sameer E. Al-Harthi
2011
Over-expression of mitogen-activated protein kinase phosphatase-2 enhances adhesion molecule expression and protects against apoptosis in human endothelial cells.
Sameer E. Al-Harthi
2010